APA

Visser M. E., Kropman E., Kranendonk M. E., Koppen A., Hamers N., Stroes E. S., Kalkhoven E. & Monajemi H. (20111004). Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C). : Diabetologia.

Chicago

Visser M E, Kropman E, Kranendonk M E, Koppen A, Hamers N, Stroes E S, Kalkhoven E and Monajemi H. 20111004. Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C). : Diabetologia.

Harvard

Visser M. E., Kropman E., Kranendonk M. E., Koppen A., Hamers N., Stroes E. S., Kalkhoven E. and Monajemi H. (20111004). Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C). : Diabetologia.

MLA

Visser M E, Kropman E, Kranendonk M E, Koppen A, Hamers N, Stroes E S, Kalkhoven E and Monajemi H. Characterisation of non-obese diabetic patients with marked insulin resistance identifies a novel familial partial lipodystrophy-associated PPARγ mutation (Y151C). : Diabetologia. 20111004.